Metformin: historical overview. (Q48004913)

7 February 2018

editorial

0 references

title

Metformin: historical overview. (English)

1 reference

7 February 2018

1 reference

1

1 reference

7 February 2018

publication date

3 August 2017

1 reference

7 February 2018

published in

Diabetologia

1 reference

7 February 2018

volume

60

1 reference

7 February 2018

page(s)

1566-1576

1 reference

7 February 2018

issue

9

1 reference

7 February 2018

https://scigraph.springernature.com/pub.10.1007/s00125-017-4318-z

exact match

0 references

cites work

Metformin: its botanical background

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4318-Z

über Synthetisch Dargestellte Körper mit Insulinartiger Wirkung Auf den Normalen und Diabetischen Organismus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4318-Z

CCXIV.?The preparation of methylguanidine, and of ??-dimethylguanidine by the interaction of dicyanodiamide, and methylammonium and dimethylammonium chlorides respectively

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4318-Z

Über Biguanide, II.: Die blutzucker-senkende Wirkung der Biguanide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4318-Z

Hypoglycemic Agents. III.1—3N1-Alkyl- and Aralkylbiguanides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4318-Z

Comparison of chlorpropamide and metformin treatment on weight and blood-glucose response of uncontrolled obese diabetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4318-Z

Comparison of metformin and chlorpropamide in non-obese, maturity-onset diabetics uncontrolled by diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4318-Z

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4318-Z

Phenethyldiguanide: a dangerous side-effect.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4318-Z

Lactic acidosis in biguanide-treated diabetics: a review of 330 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4318-Z

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4318-Z

Lactic acidosis induced by metformin: incidence, management and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4318-Z

Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4318-Z

Banting lecture 1988. Role of insulin resistance in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4318-Z

Inhibition of hepatic gluconeogenesis by metformin. Synergism with insulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4318-Z

Effect of metformin on glucose metabolism in the splanchnic bed

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4318-Z

Importance of the intestine as a site of metformin-stimulated glucose utilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4318-Z

Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4318-Z

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4318-Z

Gastrointestinal tolerability of extended-release metformin tablets compared to immediate-release metformin tablets: results of a retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4318-Z

Simultaneous glyburide/metformin therapy is superior to component monotherapy as an initial pharmacological treatment for type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4318-Z

Fixed-dose single tablet antidiabetic combinations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4318-Z

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4318-Z

Metformin: effects on micro and macrovascular complications in type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4318-Z

Reduced cardiovascular morbidity and mortality associated with metformin use in subjects with Type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4318-Z

Improved clinical outcomes associated with metformin in patients with diabetes and heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4318-Z

10-year follow-up of intensive glucose control in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4318-Z

Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4318-Z

CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2017 EXECUTIVE SUMMARY.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4318-Z

Oral Pharmacologic Treatment of Type 2 Diabetes Mellitus: A Clinical Practice Guideline Update From the American College of Physicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4318-Z

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4318-Z

Therapeutic Use of Metformin in Prediabetes and Diabetes Prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4318-Z

Metformin versus insulin for the treatment of gestational diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4318-Z

Metformin for the treatment of the polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4318-Z

Metformin and reduced risk of cancer in diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4318-Z

The influence of glucose-lowering therapies on cancer risk in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4318-Z

Metformin as a Tool to Target Aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4318-Z

Metformin and the gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4318-Z

Clinical pharmacokinetics of metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4318-Z

The antihyperglycaemic effect of metformin: therapeutic and cellular mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-017-4318-Z

Pharmacological studies of a new oral hypoglycemic drug.

21 January 2018

1 reference

12 December 2020

Metformin: a review of its pharmacological properties and therapeutic use

1 reference

12 December 2020

Studies on synthetic antimalarial drugs; some biguanide derivatives as new types of antimalarial substances with both therapeutic and causal prophylactic activity.

1 reference

12 December 2020

Clinical experience with DBI (phenformin) in the management of diabetes

1 reference

12 December 2020

OBSERVATIONS ON THE USE OF SYNTHALIN IN THE TREATMENT OF DIABETES MELLITUS.

1 reference

12 December 2020

MECHANISM OF ACTION OF ANTIDIABETIC BIGUANIDES

1 reference

12 December 2020

[Treatment of diabetes with N,N-dimethyl diguanide (LA 6023).]

1 reference

12 December 2020

Goat's rue - French lilac - Italian fitch - Spanish sainfoin: gallega officinalis and metformin: the Edinburgh connection

1 reference

12 December 2020

The effects of phenformin on peripheral glucose utilization and insulin action in obesity and diabetes mellitus

1 reference

12 December 2020

[Report on 5-years' experience with dimethylbiguanide (metformin, glucophage) in diabetic therapy.]

1 reference

12 December 2020

The toxicity and general pharmacology of N1-p-chlorophenyl-N5-isopropyl biguanide

1 reference

12 December 2020

Metformin in the treatment of HIV lipodystrophy syndrome: A randomized controlled trial

1 reference

12 December 2020

1 reference

12 December 2020

Accumulation of metformin by tissues of the normal and diabetic mouse

1 reference

12 December 2020

Therapeutic approach in insulin resistance with acanthosis nigricans

1 reference

12 December 2020

Genetic impairment of phenformin metabolism

1 reference

12 December 2020

[Further results of diabetes therapy with blood sugar lowering biguanides.]

1 reference

12 December 2020

Metformin in the diabetic brain: friend or foe?

1 reference

12 December 2020

[Treatment of diabetes mellitus with biguanides.]

1 reference

12 December 2020

Dimethyldiguanide in the treatment of diabetic children

1 reference

12 December 2020

[Blood sugar-lowering effect of 1,1-dimethylbiguanide.]

1 reference

12 December 2020

The University Group Diabetes Program. A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. V. Evaluation of pheniformin therapy

1 reference

12 December 2020

Biguanides. A review of history, pharmacodynamics and therapy

1 reference

12 December 2020

Worldwide experience of metformin as an effective glucose-lowering agent: a meta-analysis

1 reference

12 December 2020

Effect of metformin on glucose metabolism in mouse soleus muscle

1 reference

12 December 2020

Defective hydroxylation of phenformin as a determinant of drug toxicity

1 reference

12 December 2020

Flumamine, a new synthetic analgesic and anti-flu drug

1 reference

12 December 2020

[Treatment of diabetes mellitus with N,N-dimethylguanylguanidine (LA. 6023, glucophage)]

1 reference

12 December 2020

EXPERIMENTAL BASIS FOR COMBINED TREATMENT OF DIABETES WITH THE BIGUANIDE-SULFONAMIDE ASSOCIATION

1 reference

12 December 2020

10.1007/S00125-017-4318-Z

Identifiers

DOI

1 reference

7 February 2018

PubMed ID

28776081

1 reference

7 February 2018